Skip to search formSkip to main contentSkip to account menu

DL-8280

Known as: DL 8280, DL8280 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Ofloxacin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
Prediction of the effect of ofloxacine on intestinal absorption: effect of the body weight and substrate concentration.
1985
1985
新抗菌物質 Ofloxacin (DL8280) の肺結核に対する臨床効果 (1年投与の成績)
1984
1984
[Comparison of DL-8280 and amoxicillin in the treatment of respiratory tract infections].
1984
1984
METABOLIC DISPOSITION OF DL-8280:THE FIRST REPORT: COMPARISON BETWEEN ABSORPTION AND EXCRETION OF DL-8280 IN THE DOG AND MONKEY BY BIOASSAY AND HPLC METHODS
1984
1984
[In vitro antituberculous activity of DL8280 on Mycobacterium tuberculosis. The mode of bacteriostatic activity, bactericidal activity, cross-resistance and combined effect with other antituberculous…
1984
1984
BACTERIOLOGICAL AND CLINICAL EVALUATION OF DL-8280 IN THE FIELD OF RESPIRATORY AND URINARY TRACT INFECTIONS
1984
1984
[Clinical studies on DL-8280 in male gonococcal urethritis].
1984
1984
[Prostatic tissue and fluid levels of DL-8280].
The concentration of DL-8280, a new pyridone carboxylic acid, in the prostatic tissue and fluid after oral administration to man… 
1984
1984
BACTERIOLOGICAL AND CLINICAL STUDIES ON DL-8280
1983
1983
In Vitro Antimycobacterial Activity of a New Antibacterial Substance DL‐8280—Differentiation between Some Species of Mycobacteria and Related Organisms by the DL‐8280 Susceptibility Test
DL-8280 is an antibacterial agent synthesized by the Daiichi Pharmaceutical Company, Tokyo, and has the following chemical… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)